APA (7th ed.) Citation

Patel, J. D., Hensing, T. A., Rademaker, A., Hart, E. M., Blum, M. G., Milton, D. T., & Bonomi, P. D. (2009). Phase II Study of Pemetrexed and Carboplatin Plus Bevacizumab With Maintenance Pemetrexed and Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer. Journal of clinical oncology, 27(20), 3284-3289. https://doi.org/10.1200/JCO.2008.20.8181

Chicago Style (17th ed.) Citation

Patel, Jyoti D., Thomas A. Hensing, Alfred Rademaker, Eric M. Hart, Matthew G. Blum, Daniel T. Milton, and Philip D. Bonomi. "Phase II Study of Pemetrexed and Carboplatin Plus Bevacizumab With Maintenance Pemetrexed and Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer." Journal of Clinical Oncology 27, no. 20 (2009): 3284-3289. https://doi.org/10.1200/JCO.2008.20.8181.

MLA (9th ed.) Citation

Patel, Jyoti D., et al. "Phase II Study of Pemetrexed and Carboplatin Plus Bevacizumab With Maintenance Pemetrexed and Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer." Journal of Clinical Oncology, vol. 27, no. 20, 2009, pp. 3284-3289, https://doi.org/10.1200/JCO.2008.20.8181.